FDA
- Status: approved
At least one dose of HAV (At least one dose of HAV) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
LiuZhou People's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.